APTO Forecast and Technical Stock Analysis
Sell candidate since 2019-08-14 Loss -4.45%
Aptose Biosciences fell by -3.28% in the last day ( Monday, 19th Aug 2019 ) from $2.44 to $2.36 During the day the stock fluctuated 6.03% from a day low at $2.32 to a day high of $2.46. The price has been going up and down for this period, and there has been a 3.51% gain for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -67 755 shares and in total 363 598 shares bought and sold for approximately $858 091.00.
Quick summary:
- 30 day high of the APTO stock price was $2.99 and low was $2.10.
- 90 day high was $3.13 and low was $1.81.
- 52 week high for Aptose Biosciences - $3.20 and low - $1.57.
Trend
Aptose Biosciences has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $2.40. A reaction back to this level may hold a second chance to get out before further falls.
Signals
There are few to none technical positive signals at the moment. Aptose Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.52 and $2.65. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday August 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 42 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aptose Biosciences finds support from accumulated volume at $2.35.
Risk
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 6.03%. For the last week the stock has had a daily average volatility of 7.49%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
7.49 %
Average volatilityOverall risk:
Very Low Low Medium High Very High
Evaluation
The Aptose Biosciences stock holds several negative signals and despite the positive trend we believe Aptose Biosciences will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Trading With Moving Average
As an investor, you always seek to understand what other... Full ArticlePivot Points
Pivot Points refer to points of significant change. As a... Full ArticleAccumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full ArticleVolume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full ArticleWe Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full ArticleBetter Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full ArticleProudly made at
